Oculis Updates Share Capital
Rhea-AI Summary
Oculis Holding AG (Nasdaq: OCS) has announced an update to its share capital structure. The company has issued 589,974 new registered ordinary shares with a nominal value of CHF 0.01 each. This issuance consists of:
- 310,941 shares issued for equity awards under the Company's Stock Option and Incentive Plan
- 279,033 shares issued through EBAC warrant exercises
Following these issuances, which occurred between January 1, 2024, and December 31, 2024, Oculis's total registered shares have increased to 54,533,674. The change has been officially registered with the Zug Commercial Register.
Positive
- None.
Negative
- None.
ZUG, Switzerland, April 25, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each with a nominal value of CHF 0.01. The issuance comprises 589,974 registered shares, reflecting the settlement of 310,941 shares issued in connection with the exercise of equity awards under the Company’s Stock Option and Incentive Plan Regulation and 279,033 shares issued through EBAC warrant exercises pursuant to the Company‘s Articles of Association, during the period from January 1, 2024, to December 31, 2024.
As a result, the total number of registered shares as set forth in the Company’s Articles of Association has increased to 54,533,674. This increase has been registered with the Zug Commercial Register.
For more information, please visit:
http://www.oculis.com
Oculis Contact:
Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com
Investor & Media Relations:
LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com
FAQ
How many new shares did Oculis (OCS) issue in 2024?
What is the total number of registered shares for Oculis (OCS) after the 2024 issuance?
What was the purpose of Oculis's (OCS) share issuance in 2024?
What is the nominal value of Oculis's (OCS) newly issued shares?
